Literature DB >> 8031267

Nonsteroidal anti-inflammatory drugs and cataract surgery.

L M Jampol, S Jain, B Pudzisz, R N Weinreb.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 8031267     DOI： 10.1001/archopht.1994.01090190039018

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN： 0003-9950


× No keyword cloud information.
  5 in total

1.  Nepafenac, a unique nonsteroidal prodrug with potential utility in the treatment of trauma-induced ocular inflammation: I. Assessment of anti-inflammatory efficacy.

Authors:  D A Gamache; G Graff; M T Brady; J M Spellman; J M Yanni
Journal:  Inflammation       Date:  2000-08       Impact factor: 4.092

Review 2.  Topical nonsteroidal anti-inflammatory drugs for ophthalmic use: a safety review.

Authors:  Bruce I Gaynes; Richard Fiscella
Journal:  Drug Saf       Date:  2002       Impact factor: 5.606

3.  Topical ophthalmic NSAIDs: a discussion with focus on nepafenac ophthalmic suspension.

Authors:  Bruce I Gaynes; Anne Onyekwuluje
Journal:  Clin Ophthalmol       Date:  2008-06

4.  Topical nepafenac 0.1% alone versus prednisolone acetate 1% as postoperative anti-inflammatory agents in small gauge vitrectomy.

Authors:  Manish Nagpal; Sarang Lambat; Navneet Mehrotra; Gaurav Paranjpe; Harsh Yadav; Sidharth Bhardwaj
Journal:  Indian J Ophthalmol       Date:  2014-05       Impact factor: 1.848

5.  Commentary: Let us ponder - Choosing between topical Nepafenac and topical steroids after cataract surgery.

Authors:  Amruta S Tripathi
Journal:  Indian J Ophthalmol       Date:  2022-03       Impact factor: 2.969
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.